Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-08

Clinical Trial Update: Apremilast in the Treatment of Uveitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of apremilast for uveitis was terminated, with results posted on 2014-07-08.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OTEZLA (apremilast)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Uveitis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-07-08